Jamie Murphy
Comptroller/Controller/Auditor bij SIGILON THERAPEUTICS, INC.
Profiel
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Actieve functies van Jamie Murphy
| Bedrijven | Functie | Begin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Eerdere bekende functies van Jamie Murphy
| Bedrijven | Functie | Einde |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Opleiding van Jamie Murphy
| Wake Forest University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
